UTHR United Therapeutics Corporation
$591.20▼ -0.28%
Healthcare
Other
After hours
$591.20▲ +0.00%
Oct 27, 4:53 PM ET
Volume 440.2K
Avg Volume (10D) 612.1K
Key Metrics & Fundamentals
Market Cap
$25.36B
P/E Ratio
21.2
Div Yield
0.00%
52W Range
409.07 - 609.35
% vs 50 MA
13.06%
% vs 200 MA
11.59%
RSI-14
69.5
MACD Histogram
+4.7800
Beta (1Y vs SPY)
0.23
Free Cash Flow
$205.60M
Gross Rev
$783.30M
Gross Profit
$683.80M
EBITDA
$399.80M
COGS
$99.50M
Operating Exp
$353.00M
Operating Income
$330.80M
EBIT
$330.80M
Pretax Income
$372.70M
Net Income
$333.00M
EPS (Diluted)
7.27
Price & Volume History
Loading chart…
Recent News
United Therapeutics Insider Sold Shares Worth $5,536,235, According to a Recent SEC Filing
MT Newswires · Oct 26, 2026 4:38 PM ET
Can Liquidia (LQDA) Still Justify Its Price After Settlement?
Simply Wall St. · Oct 24, 2026 8:08 AM ET
2 healthcare stocks to keep an eye on and 1 that underwhelm
StockStory · Oct 23, 2026 3:44 PM ET
What State Street SPDR S&P MidCap 400 ETF (MDY) Bought: Okta Leads on Oct. 21
GuruFocus.com · Oct 23, 2026 7:05 AM ET
United Therapeutics Insider Sold Shares Worth $5,320,681, According to a Recent SEC Filing
MT Newswires · Oct 22, 2026 4:43 PM ET
Sector Update: Healthcare Stocks Gain Late Afternoon
MT Newswires · Oct 22, 2026 3:56 PM ET
Sector Update: Healthcare Stocks Advance Thursday Afternoon
MT Newswires · Oct 22, 2026 1:44 PM ET
Sector Update: Healthcare
MT Newswires · Oct 22, 2026 1:09 PM ET
United Therapeutics' Tyvaso Outlook Faces Near-Term Pressure After Liquidia Settlement, RBC Says
MT Newswires · Oct 22, 2026 11:35 AM ET
United Therapeutics Authorizes New $2 Billion Stock Buyback Program
MT Newswires · Oct 22, 2026 9:13 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See UTHR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.